Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort. [electronic resource]
Producer: 20180319Description: 1138-1148 p. digitalISSN:- 1600-0641
- 2-Naphthylamine
- Adult
- Aged
- Aged, 80 and over
- Anilides -- administration & dosage
- Antiviral Agents -- administration & dosage
- Benzimidazoles -- administration & dosage
- Carbamates -- administration & dosage
- Carcinoma, Hepatocellular -- etiology
- Cohort Studies
- Cyclopropanes
- Drug Therapy, Combination
- Female
- Fluorenes -- administration & dosage
- Genotype
- Glomerular Filtration Rate
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Humans
- Lactams, Macrocyclic
- Liver Neoplasms -- etiology
- Macrocyclic Compounds -- administration & dosage
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- etiology
- Proline -- analogs & derivatives
- Retrospective Studies
- Ribavirin -- administration & dosage
- Ritonavir -- administration & dosage
- Sofosbuvir
- Spain
- Sulfonamides -- administration & dosage
- Sustained Virologic Response
- Treatment Outcome
- Uracil -- administration & dosage
- Uridine Monophosphate -- administration & dosage
- Valine
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.